Aesthetic Medical International Announces Business Updates on Newly-acquired Non-surgical Business in Guangzhou
06 December 2021 - 9:30PM
Aesthetic Medical International Holdings Group Limited (Nasdaq:
AIH) (the “Company” or “AIH”), a leading provider of aesthetic
medical services in China, today announced the operational updates
on its newly-acquired non-surgical satellite clinic in Guangzhou.
To further leverage the Company’s extensive
operational experiences and resources in the Guangdong-Hong
Kong-Macao Greater Bay Area, Guangzhou Pengai Aesthetic Medical
Hospital Co., Ltd., a wholly-owned subsidy of the Company, entered
into a definitive equity transfer agreement (the “Agreement”) with
a shareholder of Guangzhou Meixi Aesthetic Medical Clinic Company
Limited (“Meixi”) on October 17, 2021. Pursuant to the Agreement,
the Company purchased 73% of equity interests in Meixi from its
existing shareholder. Meixi’s name was changed to Guangzhou Pengai
Xiuqi Aesthetic Medical Clinic Co., Ltd (“Guangzhou Xiuqi”), and
its financial statement was consolidated by AIH in November 2021.
Currently, Guangzhou Xiuqi operates a non-surgical satellite clinic
with a gross floor area of approximately 900 square meters and nine
consulting rooms (the “Clinic”).
Under the Company’s dedicated efforts, the
Company recorded a satisfactory operating result in November 2021,
and RMB2.3 million of which was contributed by cash sales from the
Clinic. The Company believes that the encouraging operating result
of the Clinic showcases its success in the non-surgical aesthetic
market after the establishment of the Beijing satellite clinic, and
thus reaffirms its strategic plan to expand its non-surgical
aesthetic medical business.
About Aesthetic Medical International
Holdings Group Limited
AIH, known as “Peng’ai” in China, is a leading
provider of aesthetic medical services in China. AIH operates
through treatment centers that spread across major cities in
mainland China, and also has presence in Hong Kong and Singapore.
Leveraging over 20 years of clinical experience, AIH provides
one-stop aesthetic service offerings, including surgical aesthetic
treatments, non-surgical aesthetic treatments, general medical
services and other aesthetic services. According to a certain third
party industry consultant, AIH was the third-largest private
aesthetic medical services provider in China in terms of revenue in
2018. For more information regarding the Company, please visit:
https://ir.aihgroup.net/.
Safe Harbor Statement
This press release contains “forward-looking
statements.” These statements are made under the “safe harbor”
provisions of the U.S. Private Securities Litigation Reform Act of
1995. These forward-looking statements can be identified by
terminology such as “will,” “expects,” “anticipates,” “aims,”
“future,” “intends,” “plans,” “believes,” “estimates,” “likely to”
and similar statements. Statements that are not historical facts,
including statements about the Company’s beliefs, plans and
expectations, are forward-looking statements. Forward-looking
statements involve inherent risks and uncertainties. These risks
and uncertainties and others that relate to the Company’s business,
financial condition and industry are detailed from time to time in
the Company’s SEC filings, and could cause the actual results to
differ materially from those contained in any forward-looking
statements. These forward-looking statements are made only as of
the date indicated, and the Company undertakes no obligation to
update or revise the information contained in any forward-looking
statements, except as required under applicable law.
Investor Relations Contacts
For investor and media inquiries, please
contact:
Aesthetic Medical International Holdings Group
LimitedEmail: ir@pengai.com.cn
DLK Advisory Limited Tel: +852 2857 7101Email:
ir@dlkadvisory.com
Aesthetic Medical (NASDAQ:AIH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aesthetic Medical (NASDAQ:AIH)
Historical Stock Chart
From Apr 2023 to Apr 2024